참고문헌
- Ravetch JV, Lanier LL: Immune inhibitory receptors. Science 290;84-89, 2000 https://doi.org/10.1126/science.290.5489.84
- Lanier LL: Face off--the interplay between activating and inhibitory immune receptors. Curr Opin Immunol 13;326-331, 2001 https://doi.org/10.1016/S0952-7915(00)00222-3
-
Malbec O, Fong DC, Turner M, Tybulewicz VL, Cambier JC, Fridman WH, Da
$\ddot{e}$ ron M: Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation. J Immunol 160;1647-1658, 1998 - Smith KM, Wu J, Bakker AB, Phillips JH, Lanier LL: Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors. J Immunol 161;7-10, 1998
- Lanier LL, Bakker AB: The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today 21;611-614, 2000 https://doi.org/10.1016/S0167-5699(00)01745-X
- Love PE, Shores EW: ITAM multiplicity and thymocyte selection:how low can you go? Immunity 12;591-597, 2000 https://doi.org/10.1016/S1074-7613(00)80210-1
- Takai T, Ono M: Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family. Immunol Rev 181;215-222, 2001 https://doi.org/10.1034/j.1600-065X.2001.1810118.x
- Martin AM, Kulski JK, Witt C, Pontarotti P, Christiansen FT:Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol 23;81-88, 2002 https://doi.org/10.1016/S1471-4906(01)02155-X
- Nathan C: Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 6;173-182, 2006 https://doi.org/10.1038/nri1785
- Kumagai H, Oki T, Tamitsu K, Feng SZ, Ono M, Nakajima H, Bao YC, Kawakami Y, Nagayoshi K, Copeland NG, Gilbert DJ, Jenkins NA, Kawakami T, Kitamura T: Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells. Biochem Biophys Res Commun 307;719-729, 2003 https://doi.org/10.1016/S0006-291X(03)01245-2
- Chung DH, Humphrey MB, Nakamura MC, Ginzinger DG, Seaman WE, Daws MR: CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J Immunol 171;6541-6548, 2003 https://doi.org/10.4049/jimmunol.171.12.6541
- Luo K, Zhang W, Sui L, Li N, Zhang M, Ma X, Zhang L, Cao X: DIgR1, a novel membrane receptor of the immunoglobulin gene superfamily, is preferentially expressed by antigen-presenting cells. Biochem Biophys Res Commun 287;35-41, 2001 https://doi.org/10.1006/bbrc.2001.5539
- Nakano T, Tahara-Hanaoka S, Nakahashi C, Can I, Totsuka N, Honda S, Shibuya K, Shibuya A: Activation of neutrophils by a novel triggering immunoglobulin-like receptor MAIR-IV. Mol Immunol 45;289-294, 2008 https://doi.org/10.1016/j.molimm.2007.04.011
- Fujimoto M, Takatsu H, Ohno H: CMRF-35-like molecule-5 constitutes novel paired receptors, with CMRF-35-like molecule-1, to transduce activation signal upon association with FcRgamma. Int Immunol 18;1499-1508, 2006 https://doi.org/10.1093/intimm/dxl083
- Shi L, Luo K, Xia D, Chen T, Chen G, Jiang Y, Li N, Cao X: DIgR2, dendritic cell-derived immunoglobulin receptor 2, is one representative of a family of IgSF inhibitory receptors and mediates negative regulation of dendritic cellnitiated antigen-specific T-cell responses. Blood 108;2678-2686, 2006 https://doi.org/10.1182/blood-2006-04-015404
- Cantoni C, Bottino C, Augugliaro R, Morelli L, Marcenaro E, Castriconi R, Vitale M, Pende D, Sivori S, Millo R, Biassoni R, Moretta L, Moretta A: Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol 29;3148-3159, 1999 https://doi.org/10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L
- Clark GJ, Green BJ, Hart DN: The CMRF-35H gene structure predicts for an independently expressed member of an ITIM/ITAM pair of molecules localized to human chromosome 17. Tissue Antigens 55;101-109, 2000 https://doi.org/10.1034/j.1399-0039.2000.550201.x
- Clark GJ, Cooper B, Fitzpatrick S, Green BJ, Hart DN: The gene encoding the immunoregulatory signaling molecule CMRF-35A localized to human chromosome 17 in close proximity to other members of the CMRF-35 family. Tissue Antigens 57;415-423, 2001 https://doi.org/10.1034/j.1399-0039.2001.057005415.x
- Yotsumoto K, Okoshi Y, Shibuya K, Yamazaki S, Taharaanaoka S, Honda S, Osawa M, Kuroiwa A, Matsuda Y, Tenen DG, Iwama A, Nakauchi H, Shibuya A: Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation. J Exp Med 198;223-233, 2003 https://doi.org/10.1084/jem.20021825
- Nakahashi C, Tahara-Hanaoka S, Totsuka N, Okoshi Y, Takai T, Ohkohchi N, Honda S, Shibuya K, Shibuya A: Dual assemblies of an activating immune receptor, MAIR-II, with ITAM-bearing adapters DAP12 and FcRgamma chain on peritoneal macrophages. J Immunol 178;765-770, 2007 https://doi.org/10.4049/jimmunol.178.2.765
- Okoshi Y, Tahara-Hanaoka S, Nakahashi C, Honda S, Miyamoto A, Kojima H, Nagasawa T, Shibuya K, Shibuya A: Requirement of the tyrosines at residues 258 and 270 of MAIR-I in inhibitory effect on degranulation from basophilic leukemia RBL-2H3. Int Immunol 17;65-72, 2005 https://doi.org/10.1093/intimm/dxh187
- Takaki R, Watson SR, Lanier LL: DAP12: an adapter protein with dual functionality. Immunol Rev 214;118-129, 2006 https://doi.org/10.1111/j.1600-065X.2006.00466.x
- Kim MK, Huang ZY, Hwang PH, Jones BA, Sato N, Hunter S, Kim-Han TH, Worth RG, Indik ZK, Schreiber AD:Fcgamma receptor transmembrane domains: role in cell surface expression, gamma chain interaction, and phagocytosis. Blood 101;4479-4484, 2003 https://doi.org/10.1182/blood.V101.11.4479
- Can I, Tahara-Hanaoka S, Hitomi K, Nakano T, Nakahashida C, Kurita N, Honda S, Shibuya K, Shibuya A: Caspase-independent cell death by CD300LF (MAIR-V), an inhibitory immunoglobulin-like receptor on myeloid cells. J Immunol 180;207-213, 2008 https://doi.org/10.4049/jimmunol.180.1.207
피인용 문헌
- An immunoglobulin-like receptor, Allergin-1, inhibits immunoglobulin E–mediated immediate hypersensitivity reactions vol.11, pp.7, 2009, https://doi.org/10.1038/ni.1886
- CD300F Blocks Both MyD88 and TRIF-Mediated TLR Signaling through Activation of Src Homology Region 2 Domain-Containing Phosphatase 1 vol.186, pp.11, 2009, https://doi.org/10.4049/jimmunol.1002184
- Synthetic Peptides Containing ITIM-Like Domains Block Expression of Inflammatory Mediators and Migration/Invasion of Cancer Cells Through Activation of SHP-1 and PI3K vol.30, pp.5, 2009, https://doi.org/10.3109/07357907.2012.664671
- SHPS-1 and a synthetic peptide representing its ITIM inhibit the MyD88, but not TRIF, pathway of TLR signaling through activation of SHP and PI3K in THP-1 cells vol.62, pp.4, 2009, https://doi.org/10.1007/s00011-013-0589-0
- The Role of Natural Cytotoxicity Receptors in Various Pathologies: Emphasis on Type I Diabetes vol.5, pp.None, 2009, https://doi.org/10.3389/fimmu.2014.00004
- Involvement of CD300a Phosphatidylserine Immunoreceptor in Aluminum Salt Adjuvant–Induced Th2 Responses vol.194, pp.11, 2009, https://doi.org/10.4049/jimmunol.1402915
- The Biology and Disease Relevance of CD300a, an Inhibitory Receptor for Phosphatidylserine and Phosphatidylethanolamine vol.194, pp.11, 2009, https://doi.org/10.4049/jimmunol.1500304
- Identification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor Family vol.290, pp.36, 2015, https://doi.org/10.1074/jbc.m115.643361
- Nrf2 activation mediates tumor-specific hepatic stellate cells-induced DIgR2 expression in dendritic cells vol.11, pp.23, 2009, https://doi.org/10.18632/aging.102554
- CD300a blockade enhances efferocytosis by infiltrating myeloid cells and ameliorates neuronal deficit after ischemic stroke vol.6, pp.64, 2009, https://doi.org/10.1126/sciimmunol.abe7915